— Know what they know.
Not Investment Advice

RXST NASDAQ

RxSight, Inc.
1W: +12.8% 1M: -14.2% 3M: -26.4% YTD: -38.8% 1Y: -61.8% 3Y: -73.0%
$6.08
-0.27 (-4.17%)
 
Weekly Expected Move ±9.6%
$5 $5 $6 $6 $7
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Sell · Power 30 · $251.9M mcap · 39M float · 1.89% daily turnover · Short 32% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$134M -3.9% ▼
5Y CAGR: +55.7%
Gross Profit
$103M +4.1% ▲
5Y CAGR: +127.1%
Operating Income
-$48M -30.7% ▼
Net Income
-$39M -41.8% ▼
EPS (Diluted)
$-0.95 -33.8% ▼
EBITDA
-$40M -66.8% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$23M$49M$89M$140M$134M
YoY Growth+53.9%+116.9%+81.8%+57.1%-3.9%
Cost of Revenue$18M$28M$35M$41M$31M
Gross Profit$5M$21M$54M$99M$103M
Gross Margin20.0%43.5%60.4%70.7%76.6%
R&D Expenses$24M$26M$29M$34M$39M
SG&A Expenses$33M$59M$75M$101M$113M
Operating Expenses$57M$85M$104M$136M$151M
Operating Income-$53M-$63M-$50M-$37M-$48M
Operating Margin-233.6%-129.2%-56.2%-26.3%-35.8%
Interest Expense$4M$5M$3M$21K$40K
Income Before Tax-$49M-$67M-$49M-$27M-$39M
Tax Expense$8K$9K$20K$50K$66K
Net Income-$49M-$67M-$49M-$27M-$39M
Net Margin-215.5%-136.2%-54.6%-19.6%-29.0%
EPS (Diluted)$-1.78$-2.41$-1.41$-0.71$-0.95
EBITDA-$41M-$58M-$41M-$24M-$40M
Shares Outstanding27M28M34M39M41M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms